A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
about
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeIon channels as drug targets in central nervous system disordersThe treatment of tremorGlutamate receptor ion channels: structure, regulation, and functionPotential future neuroprotective therapies for neurodegenerative disorders and stroke.Novel pharmacological strategies for motor complications in Parkinson's disease.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersPharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?Minority enrollment in Parkinson's disease clinical trials.Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?Glutamate receptors as therapeutic targets for Parkinson's disease.Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.Metabotropic glutamate receptors for Parkinson's disease therapy.Therapy for dyskinesias in Parkinson’s disease patients
P2860
Q21092426-29BCCC57-0CCD-4AB9-9A08-24D5E74CCBBFQ27004533-66F5ECBC-6D1A-4BC8-BE9D-E1335F6DE93FQ27022935-0AE4D71E-D373-41DC-879D-534CCE7A7588Q28290774-F020A893-DB8F-4C65-B4EF-9D0D421C22FBQ33687436-FBEF51AE-DF8C-470A-A9A8-B50B65E5953DQ36120761-7FFFDE84-3D7A-43EF-ACB6-4395B9BA8983Q36799584-8095D030-4F7C-455E-A62B-3B40ECA82EB0Q37077360-ABAFBA3B-937E-43A5-AD4A-B833C04B584EQ37236732-1B859342-9560-493F-859B-D7E136A6BCB4Q37264464-EC19E833-2CED-467F-B744-1144EA9B04FAQ37506507-D5B6FEF9-34B9-4F70-B869-F66FC0407C0EQ37585401-409AA7A5-267A-4779-AEEF-6788113DC808Q38170421-C86A4737-684D-4D23-B0E3-864CACC69786Q38174986-EBD6D5A8-733F-42D9-B7C5-B427CD0C2F35Q40027470-5255145E-11D1-45DC-9C41-6620AA48A488Q41818450-E85B45D9-9D5B-4286-BFE2-166C5DF05846Q57518128-E2B2AA87-8F7E-48A9-A713-0977421E195D
P2860
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A randomized, controlled trial ...... ations in Parkinson's disease.
@ast
A randomized, controlled trial ...... ations in Parkinson's disease.
@en
A randomized, controlled trial ...... ations in Parkinson's disease.
@en-gb
type
label
A randomized, controlled trial ...... ations in Parkinson's disease.
@ast
A randomized, controlled trial ...... ations in Parkinson's disease.
@en
A randomized, controlled trial ...... ations in Parkinson's disease.
@en-gb
prefLabel
A randomized, controlled trial ...... ations in Parkinson's disease.
@ast
A randomized, controlled trial ...... ations in Parkinson's disease.
@en
A randomized, controlled trial ...... ations in Parkinson's disease.
@en-gb
P2093
P356
P1433
P1476
A randomized, controlled trial ...... ations in Parkinson's disease.
@en
P2093
A L Lafontaine
A Siderowf
P304
P356
10.1212/WNL.56.4.455
P407
P577
2001-02-01T00:00:00Z